£795.00

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

2023-2028 World Outlook for Sickle Cell Disease Treatments

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£795.00 £755.25 £771.15 £787.05 £802.95 £818.85 £834.75 22 August 2026 31 August 2026 09 September 2026 18 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 1 price levels

Days at Price
38 days 0 10 19 29 38 £795 Days at Price

Price Analysis

Most common price: £795 (38 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 38 days

Description

This comprehensive study examines the global market for sickle cell disease treatments across more than 190 countries, providing strategic insights into latent demand and potential industry earnings. For each reported year, the report delivers estimated potential industry earnings in millions of U.S. dollars, regional market share percentages, and global positioning data for each country analysed. Using econometric models that project fundamental economic dynamics within and across countries, the study creates detailed latent demand estimates to help readers benchmark individual country markets against regional and worldwide trends. This research from ICON Group International, Inc. serves professionals in healthcare, pharmaceutical, investment, and policy sectors seeking to understand sickle cell disease treatment market opportunities and competitive positioning across international markets.

Key Features

Covers sickle cell disease treatment market outlook across more than 190 countries with country-specific latent demand estimates.

Provides potential industry earnings forecasts in millions of U.S. dollars for each year reported through 2028.

Includes regional and global market share percentages, enabling direct comparison of each country's position relative to others.

Utilises econometric models to project economic dynamics and forecast latent demand with data-driven accuracy.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
10 May 2022
Listed Since
16 May 2022

Similar Products You Might Like

The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States
89% match

The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 World Outlook for Growth Factors (Blood and Tissue)
89% match

The 2023-2028 World Outlook for Growth Factors (Blood and Tissue)

£795.00 15 Sep 2026
The 2023-2028 Outlook for Vasculitis Treatments in India
89% match

The 2023-2028 Outlook for Vasculitis Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Biologic Vasculitis Treatments in India
88% match

The 2023-2028 Outlook for Biologic Vasculitis Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Renal Anemia Treatments in the United States
88% match

The 2023-2028 Outlook for Renal Anemia Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 World Outlook for Oral Iron Therapy for Iron Deficiency Anemia
88% match

The 2023-2028 World Outlook for Oral Iron Therapy for Iron Deficiency Anemia

£795.00 15 Sep 2026
The 2023-2028 World Outlook for Pharma Contract Sales
88% match

The 2023-2028 World Outlook for Pharma Contract Sales

£795.00 15 Sep 2026
The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in the United States
88% match

The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in the United States

£520.00 27 Sep 2026
The 2025-2030 World Outlook for Immuno-Oncology
88% match

The 2025-2030 World Outlook for Immuno-Oncology

£790.00 28 Sep 2026
The 2023-2028 World Outlook for Endometrial Cancer Treatments
88% match

The 2023-2028 World Outlook for Endometrial Cancer Treatments

£795.00 15 Sep 2026
The 2026-2031 World Outlook for Amino Acid Metabolism Disorders Treatments
87% match

The 2026-2031 World Outlook for Amino Acid Metabolism Disorders Treatments

£885.00 14 Nov 2026
The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States
87% match

The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Blood Transfusion in the United States
87% match

The 2023-2028 Outlook for Blood Transfusion in the United States

£520.00 27 Sep 2026
The 2023-2028 World Outlook for Virology
87% match

The 2023-2028 World Outlook for Virology

£795.00 12 Nov 2026
2027-2032 World Outlook for Transitional Cell Bladder Cancer Therapeutics
87% match

2027-2032 World Outlook for Transitional Cell Bladder Cancer Therapeutics

£890.00 28 Sep 2026
The 2023-2028 Outlook for Liver Cirrhosis Drugs in the United States
87% match

The 2023-2028 Outlook for Liver Cirrhosis Drugs in the United States

£520.00 27 Sep 2026
2026-2031 World Outlook for Biotherapeutics Cell Line Developments
87% match

2026-2031 World Outlook for Biotherapeutics Cell Line Developments

£885.00 28 Sep 2026
The 2023-2028 World Outlook for Irritable Bowel Syndrome Treatments
87% match

The 2023-2028 World Outlook for Irritable Bowel Syndrome Treatments

£795.00 15 Sep 2026
The 2023-2028 World Outlook for Therapeutic Cancer Vaccines
87% match

The 2023-2028 World Outlook for Therapeutic Cancer Vaccines

£795.00 13 Sep 2026
The 2023-2028 Outlook for Immune-Oncology Treatments in India
87% match

The 2023-2028 Outlook for Immune-Oncology Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Orphan Biologic Drugs in India
87% match

The 2023-2028 Outlook for Orphan Biologic Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Cystic Fibrosis Therapeutics for US Zip Codes
87% match

The 2023-2028 Outlook for Cystic Fibrosis Therapeutics for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Hepatitis Therapeutics in the United States
87% match

The 2023-2028 Outlook for Hepatitis Therapeutics in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in the United States
87% match

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in the United States

£520.00 27 Sep 2026